InflaRx NV (IFRX)
1.72
+0.01
(+0.58%)
USD |
NASDAQ |
Oct 02, 16:00
1.725
0.00 (0.00%)
After-Hours: 20:00
InflaRx Price : 1.72 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 1.74 | 1.80 | 1.72 | 1.72 | 422162.0 |
| Oct 01, 2026 | 1.83 | 1.856 | 1.71 | 1.71 | 369956.0 |
| Sep 30, 2026 | 1.87 | 1.89 | 1.80 | 1.80 | 302499.0 |
| Sep 29, 2026 | 1.83 | 1.89 | 1.80 | 1.85 | 268405.0 |
| Sep 28, 2026 | 1.88 | 1.954 | 1.80 | 1.82 | 426389.0 |
| Sep 25, 2026 | 1.94 | 2.04 | 1.87 | 1.89 | 399902.0 |
| Sep 24, 2026 | 1.97 | 2.02 | 1.89 | 1.93 | 510186.0 |
| Sep 23, 2026 | 2.08 | 2.09 | 1.96 | 1.96 | 564758.0 |
| Sep 22, 2026 | 2.12 | 2.19 | 2.041 | 2.08 | 571272.0 |
| Sep 21, 2026 | 2.11 | 2.19 | 2.065 | 2.12 | 345150.0 |
| Sep 18, 2026 | 2.07 | 2.11 | 2.025 | 2.09 | 292677.0 |
| Sep 17, 2026 | 2.05 | 2.10 | 1.98 | 2.06 | 657951.0 |
| Sep 16, 2026 | 2.02 | 2.069 | 1.99 | 2.04 | 821207.0 |
| Sep 15, 2026 | 2.12 | 2.165 | 1.99 | 2.02 | 579600.0 |
| Sep 14, 2026 | 2.15 | 2.20 | 2.10 | 2.12 | 545791.0 |
| Sep 11, 2026 | 2.07 | 2.11 | 2.04 | 2.09 | 334148.0 |
| Sep 10, 2026 | 2.05 | 2.07 | 1.98 | 2.05 | 613475.0 |
| Sep 09, 2026 | 2.15 | 2.15 | 2.05 | 2.09 | 759751.0 |
| Sep 08, 2026 | 2.19 | 2.26 | 2.11 | 2.17 | 408904.0 |
| Sep 04, 2026 | 2.21 | 2.377 | 2.16 | 2.22 | 393943.0 |
| Sep 03, 2026 | 2.30 | 2.370 | 2.18 | 2.23 | 666375.0 |
| Sep 02, 2026 | 2.16 | 2.34 | 2.133 | 2.29 | 572037.0 |
| Sep 01, 2026 | 2.12 | 2.27 | 2.09 | 2.16 | 475081.0 |
| Aug 31, 2026 | 2.21 | 2.23 | 2.09 | 2.13 | 447811.0 |
| Aug 28, 2026 | 2.28 | 2.37 | 2.21 | 2.23 | 610420.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| MediGene AG | 0.10 |
| BioNTech SE | 96.90 |
| Immatics NV | 7.59 |
| Arrowhead Pharmaceuticals, Inc. | 64.19 |
| Oncolytics Biotech, Inc. | 0.631 |
Price Related Metrics
| PS Ratio | 1930.26 |
| Price to Book Value | 1.517 |
| Earnings Yield | -37.70% |
| Market Cap | 253.47M |